Docket #: S24-024
Method for Generating Endothelial Cells from Pluripotent Stem Cells
Stanford researchers have developed a novel xeno-free, no purification, robust, quick, low-cost method for generating pure endothelial cell cultures by sequentially inducing mesodermal-lineage cells from pluripotent stem cells, using differentiation stage-specific extracellular signals. The process, conducted in a xeno-free condition, involves culturing mesoderm-lineage cells in an endothelial progenitor cell specification medium, then switching to a complete endothelial cell growth medium for maturation and expansion. Additionally, methods for screening optimal extracellular signal cocktails are provided for each differentiation stage. These methods allow for the mass production of high-purity vascular endothelial cells in large quantities, within a short time frame.
Stage of Development
In vitro
Applications
- iPSC-EC differentiation kit
- iPSC-ECs for basic and translational research of vascular dysfunction
- Differentiation process mimics the developmental trajectory of this cell type in vivo, therefore, it is a great model to understand genetic variants or environmental risk factor-induced developmental defects of this cell type in congenital heart disease
Advantages
- Xeno-free system for the first time
- No purification is required
- High efficiency: 98% CD31+/CD144+ cells as compared to 20% by most existing protocols
- Rapid generation of cells: with 5-6 days of differentiation versus 14-28 days by most existing protocols
- Highly expandable: up to 8 passages versus 2-3 passages by existing protocols
Publications
- Manuscript in preparation.
Related Links
Similar Technologies
-
A method to generate cardiac pericytes from human induced pluripotent stem cells S22-436A method to generate cardiac pericytes from human induced pluripotent stem cells
-
Rapid generation of human forebrain, midbrain, and hindbrain cells from human pluripotent stem cells S23-285Rapid generation of human forebrain, midbrain, and hindbrain cells from human pluripotent stem cells
-
Chimeric pseudoislets development method that retains beta cell features S22-359Chimeric pseudoislets development method that retains beta cell features